Global Coagulation Factor IX Market Research Report 2020


This report focuses on Coagulation Factor IX volume and value at global level, regional level and company level. From a global perspective, this report represents overall Coagulation Factor IX market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
    Pfizer
    CSL Behring
    Grifols
    Novo Nordisk
    Bioverativ
    Sanquin
    Takeda
    Baxter
    Aptevo

Segment by Regions
    North America
    Europe
    China
    Japan

Segment by Type
    Coagulation Factor IX (Plasma Derived)
    Coagulation Factor IX (Recombinant)

Segment by Application
    Adult
    Kids
Table of Contents

1 Coagulation Factor IX Market Overview
    1.1 Product Overview and Scope of Coagulation Factor IX
    1.2 Coagulation Factor IX Segment by Type
        1.2.1 Global Coagulation Factor IX Sales Growth Rate Comparison by Type (2021-2026)
        1.2.2 Coagulation Factor IX (Plasma Derived)
        1.2.3 Coagulation Factor IX (Recombinant)
    1.3 Coagulation Factor IX Segment by Application
        1.3.1 Coagulation Factor IX Sales Comparison by Application: 2020 VS 2026
        1.3.2 Adult
        1.3.3 Kids
    1.4 Global Coagulation Factor IX Market Size Estimates and Forecasts
        1.4.1 Global Coagulation Factor IX Revenue 2015-2026
        1.4.2 Global Coagulation Factor IX Sales 2015-2026
        1.4.3 Coagulation Factor IX Market Size by Region: 2020 Versus 2026

2 Global Coagulation Factor IX Market Competition by Manufacturers
    2.1 Global Coagulation Factor IX Sales Market Share by Manufacturers (2015-2020)
    2.2 Global Coagulation Factor IX Revenue Share by Manufacturers (2015-2020)
    2.3 Global Coagulation Factor IX Average Price by Manufacturers (2015-2020)
    2.4 Manufacturers Coagulation Factor IX Manufacturing Sites, Area Served, Product Type
    2.5 Coagulation Factor IX Market Competitive Situation and Trends
        2.5.1 Coagulation Factor IX Market Concentration Rate
        2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
        2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
    2.7 Primary Interviews with Key Coagulation Factor IX Players (Opinion Leaders)

3 Coagulation Factor IX Retrospective Market Scenario by Region
    3.1 Global Coagulation Factor IX Retrospective Market Scenario in Sales by Region: 2015-2020
    3.2 Global Coagulation Factor IX Retrospective Market Scenario in Revenue by Region: 2015-2020
    3.3 North America Coagulation Factor IX Market Facts & Figures by Country
        3.3.1 North America Coagulation Factor IX Sales by Country
        3.3.2 North America Coagulation Factor IX Sales by Country
        3.3.3 U.S.
        3.3.4 Canada
    3.4 Europe Coagulation Factor IX Market Facts & Figures by Country
        3.4.1 Europe Coagulation Factor IX Sales by Country
        3.4.2 Europe Coagulation Factor IX Sales by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 U.K.
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific Coagulation Factor IX Market Facts & Figures by Region
        3.5.1 Asia Pacific Coagulation Factor IX Sales by Region
        3.5.2 Asia Pacific Coagulation Factor IX Sales by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
        3.5.12 Philippines
        3.5.13 Vietnam
    3.6 Latin America Coagulation Factor IX Market Facts & Figures by Country
        3.6.1 Latin America Coagulation Factor IX Sales by Country
        3.6.2 Latin America Coagulation Factor IX Sales by Country
        3.6.3 Mexico
        3.6.3 Brazil
        3.6.3 Argentina
    3.7 Middle East and Africa Coagulation Factor IX Market Facts & Figures by Country
        3.7.1 Middle East and Africa Coagulation Factor IX Sales by Country
        3.7.2 Middle East and Africa Coagulation Factor IX Sales by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 U.A.E
4 Global Coagulation Factor IX Historic Market Analysis by Type
    4.1 Global Coagulation Factor IX Sales Market Share by Type (2015-2020)
    4.2 Global Coagulation Factor IX Revenue Market Share by Type (2015-2020)
    4.3 Global Coagulation Factor IX Price Market Share by Type (2015-2020)
    4.4 Global Coagulation Factor IX Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Global Coagulation Factor IX Historic Market Analysis by Application
    5.1 Global Coagulation Factor IX Sales Market Share by Application (2015-2020)
    5.2 Global Coagulation Factor IX Revenue Market Share by Application (2015-2020)
    5.3 Global Coagulation Factor IX Price by Application (2015-2020)

6 Company Profiles and Key Figures in Coagulation Factor IX Business
    6.1 Pfizer
        6.1.1 Corporation Information
        6.1.2 Pfizer Description, Business Overview and Total Revenue
        6.1.3 Pfizer Coagulation Factor IX Sales, Revenue and Gross Margin (2015-2020)
        6.1.4 Pfizer Products Offered
        6.1.5 Pfizer Recent Development
    6.2 CSL Behring
        6.2.1 CSL Behring Coagulation Factor IX Production Sites and Area Served
        6.2.2 CSL Behring Description, Business Overview and Total Revenue
        6.2.3 CSL Behring Coagulation Factor IX Sales, Revenue and Gross Margin (2015-2020)
        6.2.4 CSL Behring Products Offered
        6.2.5 CSL Behring Recent Development
    6.3 Grifols
        6.3.1 Grifols Coagulation Factor IX Production Sites and Area Served
        6.3.2 Grifols Description, Business Overview and Total Revenue
        6.3.3 Grifols Coagulation Factor IX Sales, Revenue and Gross Margin (2015-2020)
        6.3.4 Grifols Products Offered
        6.3.5 Grifols Recent Development
    6.4 Novo Nordisk
        6.4.1 Novo Nordisk Coagulation Factor IX Production Sites and Area Served
        6.4.2 Novo Nordisk Description, Business Overview and Total Revenue
        6.4.3 Novo Nordisk Coagulation Factor IX Sales, Revenue and Gross Margin (2015-2020)
        6.4.4 Novo Nordisk Products Offered
        6.4.5 Novo Nordisk Recent Development
    6.5 Bioverativ
        6.5.1 Bioverativ Coagulation Factor IX Production Sites and Area Served
        6.5.2 Bioverativ Description, Business Overview and Total Revenue
        6.5.3 Bioverativ Coagulation Factor IX Sales, Revenue and Gross Margin (2015-2020)
        6.5.4 Bioverativ Products Offered
        6.5.5 Bioverativ Recent Development
    6.6 Sanquin
        6.6.1 Sanquin Coagulation Factor IX Production Sites and Area Served
        6.6.2 Sanquin Description, Business Overview and Total Revenue
        6.6.3 Sanquin Coagulation Factor IX Sales, Revenue and Gross Margin (2015-2020)
        6.6.4 Sanquin Products Offered
        6.6.5 Sanquin Recent Development
    6.7 Takeda
        6.6.1 Takeda Coagulation Factor IX Production Sites and Area Served
        6.6.2 Takeda Description, Business Overview and Total Revenue
        6.6.3 Takeda Coagulation Factor IX Sales, Revenue and Gross Margin (2015-2020)
        6.4.4 Takeda Products Offered
        6.7.5 Takeda Recent Development
    6.8 Baxter
        6.8.1 Baxter Coagulation Factor IX Production Sites and Area Served
        6.8.2 Baxter Description, Business Overview and Total Revenue
        6.8.3 Baxter Coagulation Factor IX Sales, Revenue and Gross Margin (2015-2020)
        6.8.4 Baxter Products Offered
        6.8.5 Baxter Recent Development
    6.9 Aptevo
        6.9.1 Aptevo Coagulation Factor IX Production Sites and Area Served
        6.9.2 Aptevo Description, Business Overview and Total Revenue
        6.9.3 Aptevo Coagulation Factor IX Sales, Revenue and Gross Margin (2015-2020)
        6.9.4 Aptevo Products Offered
        6.9.5 Aptevo Recent Development

7 Coagulation Factor IX Manufacturing Cost Analysis
    7.1 Coagulation Factor IX Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Raw Materials Price Trend
       7.1.3 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of Coagulation Factor IX
    7.4 Coagulation Factor IX Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 Coagulation Factor IX Distributors List
    8.3 Coagulation Factor IX Customers

9 Market Dynamics
    9.1 Market Trends
    9.2 Opportunities and Drivers
    9.3 Challenges
    9.4 Porter's Five Forces Analysis

10 Global Market Forecast
    10.1 Global Coagulation Factor IX Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of Coagulation Factor IX by Type (2021-2026)
        10.1.2 Global Forecasted Revenue of Coagulation Factor IX by Type (2021-2026)
    10.2 Coagulation Factor IX Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of Coagulation Factor IX by Application (2021-2026)
        10.2.2 Global Forecasted Revenue of Coagulation Factor IX by Application (2021-2026)
    10.3 Coagulation Factor IX Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of Coagulation Factor IX by Region (2021-2026)
        10.3.2 Global Forecasted Revenue of Coagulation Factor IX by Region (2021-2026)
    10.4 North America Coagulation Factor IX Estimates and Projections (2021-2026)
    10.5 Europe Coagulation Factor IX Estimates and Projections (2021-2026)
    10.6 Asia Pacific Coagulation Factor IX Estimates and Projections (2021-2026)
    10.7 Latin America Coagulation Factor IX Estimates and Projections (2021-2026)
    10.8 Middle East and Africa Coagulation Factor IX Estimates and Projections (2021-2026)
11 Research Finding and Conclusion

12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer

List of Tables Table 1. Global Coagulation Factor IX Sales (K Units) Growth Rate Comparison by Type (2015-2026) Table 2. Global Coagulation Factor IX Sales (K Units) Comparison by Application: 2020 VS 2026 Table 3. Global Coagulation Factor IX Market Size by Type (K Units) (US$ Million) (2020 VS 2026) Table 4. Global Key Coagulation Factor IX Manufacturers Covered in This Study Table 5. Global Coagulation Factor IX Sales (K Units) by Manufacturers (2015-2020) Table 6. Global Coagulation Factor IX Sales Share by Manufacturers (2015-2020) Table 7. Global Coagulation Factor IX Revenue (Million USD) by Manufacturers (2015-2020) Table 8. Global Coagulation Factor IX Revenue Share by Manufacturers (2015-2020) Table 9. Global Market Coagulation Factor IX Average Price (USD/Unit) of Key Manufacturers (2015-2020) Table 10. Manufacturers Coagulation Factor IX Sales Sites and Area Served Table 11. Manufacturers Coagulation Factor IX Product Types Table 12. Global Coagulation Factor IX Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Coagulation Factor IX by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Coagulation Factor IX as of 2019) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Main Points Interviewed from Key Coagulation Factor IX Players Table 16. Global Coagulation Factor IX Sales (K Units) by Region (2015-2020) Table 17. Global Coagulation Factor IX Sales Market Share by Region (2015-2020) Table 18. Global Coagulation Factor IX Revenue (Million US$) by Region (2015-2020) Table 19. Global Coagulation Factor IX Revenue Market Share by Region (2015-2020) Table 20. North America Coagulation Factor IX Sales by Country (2015-2020) (K Units) Table 21. North America Coagulation Factor IX Sales Market Share by Country (2015-2020) Table 22. North America Coagulation Factor IX Revenue by Country (2015-2020) (US$ Million) Table 23. North America Coagulation Factor IX Revenue Market Share by Country (2015-2020) Table 24. Europe Coagulation Factor IX Sales by Country (2015-2020) (K Units) Table 25. Europe Coagulation Factor IX Sales Market Share by Country (2015-2020) Table 26. Europe Coagulation Factor IX Revenue by Country (2015-2020) (US$ Million) Table 27. Europe Coagulation Factor IX Revenue Market Share by Country (2015-2020) Table 28. Asia Pacific Coagulation Factor IX Sales by Region (2015-2020) (K Units) Table 29. Asia Pacific Coagulation Factor IX Sales Market Share by Region (2015-2020) Table 30. Asia Pacific Coagulation Factor IX Revenue by Region (2015-2020) (US$ Million) Table 31. Asia Pacific Coagulation Factor IX Revenue Market Share by Region (2015-2020) Table 32. Latin America Coagulation Factor IX Sales by Country (2015-2020) (K Units) Table 33. Latin America Coagulation Factor IX Sales Market Share by Country (2015-2020) Table 34. Latin America Coagulation Factor IX Revenue by Country (2015-2020) (US$ Million) Table 35. Latin America Coagulation Factor IX Revenue Market Share by Country (2015-2020) Table 36. Middle East and Africa Coagulation Factor IX Sales by Country (2015-2020) (K Units) Table 37. Middle East and Africa Coagulation Factor IX Sales Market Share by Country (2015-2020) Table 38. Middle East and Africa Coagulation Factor IX Revenue by Country (2015-2020) (US$ Million) Table 39. Middle East and Africa Coagulation Factor IX Revenue Market Share by Country (2015-2020) Table 40. Global Coagulation Factor IX Sales (K Units) by Type (2015-2020) Table 41. Global Coagulation Factor IX Sales Share by Type (2015-2020) Table 42. Global Coagulation Factor IX Revenue (Million US$) by Type (2015-2020) Table 43. Global Coagulation Factor IX Revenue Share by Type (2015-2020) Table 44. Global Coagulation Factor IX Price (USD/Unit) by Type (2015-2020) Table 45. Global Coagulation Factor IX Sales (K Units) by Application (2015-2020) Table 46. Global Coagulation Factor IX Sales Market Share by Application (2015-2020) Table 47. Global Coagulation Factor IX Sales Growth Rate by Application (2015-2020) Table 48. Pfizer Coagulation Factor IX Corporation Information Table 49. Pfizer Description and Business Overview Table 50. Pfizer Coagulation Factor IX Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 51. Pfizer Main Product Table 52. Pfizer Recent Development Table 53. CSL Behring Coagulation Factor IX Corporation Information Table 54. CSL Behring Corporation Information Table 55. CSL Behring Coagulation Factor IX Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 56. CSL Behring Main Product Table 57. CSL Behring Recent Development Table 58. Grifols Coagulation Factor IX Corporation Information Table 59. Grifols Corporation Information Table 60. Grifols Coagulation Factor IX Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 61. Grifols Main Product Table 62. Grifols Recent Development Table 63. Novo Nordisk Coagulation Factor IX Corporation Information Table 64. Novo Nordisk Corporation Information Table 65. Novo Nordisk Coagulation Factor IX Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 66. Novo Nordisk Main Product Table 67. Novo Nordisk Recent Development Table 68. Bioverativ Coagulation Factor IX Corporation Information Table 69. Bioverativ Corporation Information Table 70. Bioverativ Coagulation Factor IX Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 71. Bioverativ Main Product Table 72. Bioverativ Recent Development Table 73. Sanquin Coagulation Factor IX Corporation Information Table 74. Sanquin Corporation Information Table 75. Sanquin Coagulation Factor IX Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 76. Sanquin Main Product Table 77. Sanquin Recent Development Table 78. Takeda Coagulation Factor IX Corporation Information Table 79. Takeda Corporation Information Table 80. Takeda Coagulation Factor IX Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 81. Takeda Main Product Table 82. Takeda Recent Development Table 83. Baxter Coagulation Factor IX Corporation Information Table 84. Baxter Corporation Information Table 85. Baxter Coagulation Factor IX Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 86. Baxter Main Product Table 87. Baxter Recent Development Table 88. Aptevo Coagulation Factor IX Corporation Information Table 89. Aptevo Corporation Information Table 90. Aptevo Coagulation Factor IX Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 91. Aptevo Main Product Table 92. Aptevo Recent Development Table 93. Sales Base and Market Concentration Rate of Raw Material Table 94. Key Suppliers of Raw Materials Table 95. Coagulation Factor IX Distributors List Table 96. Coagulation Factor IX Customers List Table 97. Market Key Trends Table 98. Key Opportunities and Drivers: Impact Analysis (2021-2026) Table 99. Key Challenges Table 100. Global Coagulation Factor IX Sales (K Units) Forecast by Type (2021-2026) Table 101. Global Coagulation Factor IX Sales Market Share Forecast by Type (2021-2026) Table 102. Global Coagulation Factor IX Revenue (Million US$) Forecast by Type (2021-2026) Table 103. Global Coagulation Factor IX Revenue (Million US$) Market Share Forecast by Type (2021-2026) Table 104. Global Coagulation Factor IX Sales (K Units) Forecast by Application (2021-2026) Table 105. Global Coagulation Factor IX Revenue (Million US$) Forecast by Application (2021-2026) Table 106. Global Coagulation Factor IX Sales (K Units) Forecast by Region (2021-2026) Table 107. Global Coagulation Factor IX Sales Market Share Forecast by Region (2021-2026) Table 108. Global Coagulation Factor IX Revenue Forecast by Region (2021-2026) (US$ Million) Table 109. Global Coagulation Factor IX Revenue Market Share Forecast by Region (2021-2026) Table 110. Research Programs/Design for This Report Table 111. Key Data Information from Secondary Sources Table 112. Key Data Information from Primary Sources List of Figures Figure 1. Picture of Coagulation Factor IX Figure 2. Global Coagulation Factor IX Sales Market Share by Type: 2020 VS 2026 Figure 3. Coagulation Factor IX (Plasma Derived) Product Picture Figure 4. Coagulation Factor IX (Recombinant) Product Picture Figure 5. Global Coagulation Factor IX Consumption Market Share by Application: 2020 VS 2026 Figure 6. Adult Figure 7. Kids Figure 8. Global Coagulation Factor IX Market Size 2015-2026 (US$ Million) Figure 9. Global Coagulation Factor IX Sales Capacity (K Units) (2015-2026) Figure 10. Global Coagulation Factor IX Market Size Market Share by Region: 2020 Versus 2026 Figure 11. Coagulation Factor IX Sales Share by Manufacturers in 2020 Figure 12. Global Coagulation Factor IX Revenue Share by Manufacturers in 2019 Figure 13. The Global 5 and 10 Largest Players: Market Share by Coagulation Factor IX Revenue in 2019 Figure 14. Coagulation Factor IX Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 15. Global Coagulation Factor IX Sales Market Share by Region (2015-2020) Figure 16. Global Coagulation Factor IX Sales Market Share by Region in 2019 Figure 17. Global Coagulation Factor IX Revenue Market Share by Region (2015-2020) Figure 18. Global Coagulation Factor IX Revenue Market Share by Region in 2019 Figure 19. North America Coagulation Factor IX Sales Market Share by Country in 2019 Figure 20. North America Coagulation Factor IX Revenue Market Share by Country in 2019 Figure 21. U.S. Coagulation Factor IX Sales Growth Rate (2015-2020) (K Units) Figure 22. U.S. Coagulation Factor IX Revenue Growth Rate (2015-2020) (US$ Million) Figure 23. Canada Coagulation Factor IX Sales Growth Rate (2015-2020) (K Units) Figure 24. Canada Coagulation Factor IX Revenue Growth Rate (2015-2020) (US$ Million) Figure 25. Europe Coagulation Factor IX Sales Market Share by Country in 2019 Figure 26. Europe Coagulation Factor IX Revenue Market Share by Country in 2019 Figure 27. Germany Coagulation Factor IX Sales Growth Rate (2015-2020) (K Units) Figure 28. Germany Coagulation Factor IX Revenue Growth Rate (2015-2020) (US$ Million) Figure 29. France Coagulation Factor IX Sales Growth Rate (2015-2020) (K Units) Figure 30. France Coagulation Factor IX Revenue Growth Rate (2015-2020) (US$ Million) Figure 31. U.K. Coagulation Factor IX Sales Growth Rate (2015-2020) (K Units) Figure 32. U.K. Coagulation Factor IX Revenue Growth Rate (2015-2020) (US$ Million) Figure 33. Italy Coagulation Factor IX Sales Growth Rate (2015-2020) (K Units) Figure 34. Italy Coagulation Factor IX Revenue Growth Rate (2015-2020) (US$ Million) Figure 35. Russia Coagulation Factor IX Sales Growth Rate (2015-2020) (K Units) Figure 36. Russia Coagulation Factor IX Revenue Growth Rate (2015-2020) (US$ Million) Figure 37. Asia Pacific Coagulation Factor IX Sales Market Share by Region in 2019 Figure 38. Asia Pacific Coagulation Factor IX Revenue Market Share by Region in 2019 Figure 39. China Coagulation Factor IX Sales Growth Rate (2015-2020) (K Units) Figure 40. China Coagulation Factor IX Revenue Growth Rate (2015-2020) (US$ Million) Figure 41. Japan Coagulation Factor IX Sales Growth Rate (2015-2020) (K Units) Figure 42. Japan Coagulation Factor IX Revenue Growth Rate (2015-2020) (US$ Million) Figure 43. South Korea Coagulation Factor IX Sales Growth Rate (2015-2020) (K Units) Figure 44. South Korea Coagulation Factor IX Revenue Growth Rate (2015-2020) (US$ Million) Figure 45. India Coagulation Factor IX Sales Growth Rate (2015-2020) (K Units) Figure 46. India Coagulation Factor IX Revenue Growth Rate (2015-2020) (US$ Million) Figure 47. Australia Coagulation Factor IX Sales Growth Rate (2015-2020) (K Units) Figure 48. Australia Coagulation Factor IX Revenue Growth Rate (2015-2020) (US$ Million) Figure 49. Taiwan Coagulation Factor IX Sales Growth Rate (2015-2020) (K Units) Figure 50. Taiwan Coagulation Factor IX Revenue Growth Rate (2015-2020) (US$ Million) Figure 51. Indonesia Coagulation Factor IX Sales Growth Rate (2015-2020) (K Units) Figure 52. Indonesia Coagulation Factor IX Revenue Growth Rate (2015-2020) (US$ Million) Figure 53. Thailand Coagulation Factor IX Sales Growth Rate (2015-2020) (K Units) Figure 54. Thailand Coagulation Factor IX Revenue Growth Rate (2015-2020) (US$ Million) Figure 55. Malaysia Coagulation Factor IX Sales Growth Rate (2015-2020) (K Units) Figure 56. Malaysia Coagulation Factor IX Revenue Growth Rate (2015-2020) (US$ Million) Figure 57. Philippines Coagulation Factor IX Sales Growth Rate (2015-2020) (K Units) Figure 58. Philippines Coagulation Factor IX Revenue Growth Rate (2015-2020) (US$ Million) Figure 59. Vietnam Coagulation Factor IX Sales Growth Rate (2015-2020) (K Units) Figure 60. Vietnam Coagulation Factor IX Revenue Growth Rate (2015-2020) (US$ Million) Figure 61. Latin America Coagulation Factor IX Sales Market Share by Country in 2019 Figure 62. Latin America Coagulation Factor IX Revenue Market Share by Country in 2019 Figure 63. Mexico Coagulation Factor IX Sales Growth Rate (2015-2020) (K Units) Figure 64. Mexico Coagulation Factor IX Revenue Growth Rate (2015-2020) (US$ Million) Figure 65. Brazil Coagulation Factor IX Sales Growth Rate (2015-2020) (K Units) Figure 66. Brazil Coagulation Factor IX Revenue Growth Rate (2015-2020) (US$ Million) Figure 67. Argentina Coagulation Factor IX Sales Growth Rate (2015-2020) (K Units) Figure 68. Argentina Coagulation Factor IX Revenue Growth Rate (2015-2020) (US$ Million) Figure 69. Middle East and Africa Coagulation Factor IX Sales Market Share by Country in 2019 Figure 70. Middle East and Africa Coagulation Factor IX Revenue Market Share by Country in 2019 Figure 71. Turkey Coagulation Factor IX Sales Growth Rate (2015-2020) (K Units) Figure 72. Turkey Coagulation Factor IX Revenue Growth Rate (2015-2020) (US$ Million) Figure 73. Saudi Arabia Coagulation Factor IX Sales Growth Rate (2015-2020) (K Units) Figure 74. Saudi Arabia Coagulation Factor IX Revenue Growth Rate (2015-2020) (US$ Million) Figure 75. U.A.E Coagulation Factor IX Sales Growth Rate (2015-2020) (K Units) Figure 76. U.A.E Coagulation Factor IX Revenue Growth Rate (2015-2020) (US$ Million) Figure 77. Sales Market Share of Coagulation Factor IX by Type (2015-2020) Figure 78. Sales Market Share of Coagulation Factor IX by Type in 2019 Figure 79. Revenue Share of Coagulation Factor IX by Type (2015-2020) Figure 80. Revenue Market Share of Coagulation Factor IX by Type in 2019 Figure 81. Global Coagulation Factor IX Sales Growth by Type (2015-2020) (K Units) Figure 82. Global Coagulation Factor IX Sales Market Share by Application (2015-2020) Figure 83. Global Coagulation Factor IX Sales Market Share by Application in 2019 Figure 84. Global Revenue Share of Coagulation Factor IX by Application (2015-2020) Figure 85. Global Revenue Share of Coagulation Factor IX by Application in 2020 Figure 86. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018 Figure 87. CSL Behring Total Revenue (US$ Million): 2019 Compared with 2018 Figure 88. Grifols Total Revenue (US$ Million): 2019 Compared with 2018 Figure 89. Novo Nordisk Total Revenue (US$ Million): 2019 Compared with 2018 Figure 90. Bioverativ Total Revenue (US$ Million): 2019 Compared with 2018 Figure 91. Sanquin Total Revenue (US$ Million): 2019 Compared with 2018 Figure 92. Takeda Total Revenue (US$ Million): 2019 Compared with 2018 Figure 93. Baxter Total Revenue (US$ Million): 2019 Compared with 2018 Figure 94. Aptevo Total Revenue (US$ Million): 2019 Compared with 2018 Figure 95. Price Trend of Key Raw Materials Figure 96. Manufacturing Cost Structure of Coagulation Factor IX Figure 97. Manufacturing Process Analysis of Coagulation Factor IX Figure 98. Coagulation Factor IX Industrial Chain Analysis Figure 99. Channels of Distribution Figure 100. Distributors Profiles Figure 101. Porter's Five Forces Analysis Figure 102. North America Coagulation Factor IX Sales (K Units) and Growth Rate Forecast (2021-2026) Figure 103. North America Coagulation Factor IX Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 104. Europe Coagulation Factor IX Sales (K Units) and Growth Rate Forecast (2021-2026) Figure 105. Europe Coagulation Factor IX Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 106. Latin America Coagulation Factor IX Sales (K Units) and Growth Rate Forecast (2021-2026) Figure 107. Latin America Coagulation Factor IX Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 108. Middle East and Africa Coagulation Factor IX Sales (K Units) and Growth Rate Forecast (2021-2026) Figure 109. Middle East and Africa Coagulation Factor IX Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 110. Asia Pacific Coagulation Factor IX Sales (K Units) and Growth Rate Forecast (2021-2026) Figure 111. Asia Pacific Coagulation Factor IX Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 112. Bottom-up and Top-down Approaches for This Report Figure 113. Data Triangulation Figure 114. Key Executives Interviewed

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

New Pharmaceuticals and Healthcare Reports

Other Reports by QY Research

Global Vinyl Versatate Market Professional Survey Report 2020

The global Vinyl Versatate market was valued at US$ 328.37 million in 2019 and will reach US$ 639.42 million by the end of 2026, growing at a CAGR of 9.75% during 2021-2026. This report focuses on Vinyl Versatate volume and value at the global level,...

Global Refrigerated Containers Market Report, History and Forecast 2015-2026

Market Analysis and Insights: Global Refrigerated Containers Market In 2019, the global Refrigerated Containers market size was US$ 1376.17 million and it is expected to reach US$ 1973.42 million by the end of 2026, with a CAGR of 5.52% between 2020 ...

Global Medium-density Fiberboard Market Research Report 2020

Market Analysis and Insights: Global Medium-density Fiberboard Market The global Medium-density Fiberboard market is valued at US$ 28473.08 million in 2019 and is expected to reach US$ 41016.95 million by the end of 2027, growing at a CAGR of 4.59% d...

Global Low Voltage DC Circuit Breaker Market Professional Survey Report 2020

The global Low Voltage DC Circuit Breaker market was valued at 1237.26 million US$ in 2019 and will reach 1816.27 million US$ by the end of 2026, growing at a CAGR of 5.65% during 2020-2026. This report focuses on Low Voltage DC Circuit Breaker volum...

Global Glass Nonwovens Wet-Laid Industry Research Report Growth Trends and Competitive Analysis 2020-2026

Market Overview The Glass Nonwovens Wet-Laid market was valued at US$ 1246 million in 2019 and is projected to reach US$ 1605 million by 2026, at a CAGR of 3.68% during the forecast period. In this study, 2018 has been considered as the base year and...

Publisher: QY Research